Then patients were further analysed based on clinical data, we found that GAS6‐AS2 was positively correlated with tumour stages, and GAS6‐AS2 overexpression predicted a poorer prognosis of bladder cancer patients. The gene discussed is GAS6; the disease is neoplasm.